In a strategic move to enhance its portfolio, Jim Cramer’s Charitable Trust has purchased 50 shares of Cardinal Health at an approximate price of $217.84 each. With this new acquisition, the trust’s total holdings in Cardinal Health will rise to 400 shares, increasing its investment weight from about 2% to 2.25%. This decision comes amid a broader market downturn, yet shares of Cardinal Health have shown resilience.
Cramer and his team maintain that the recent decline in Cardinal’s stock price was unwarranted, attributing the company’s steady performance to its relative insensitivity to fluctuating oil prices, economic downturns, and ongoing geopolitical tensions. The decision to incrementally acquire shares underscores the trust’s strategy of scaling into investments over time, allowing for a potentially lower average cost basis amidst market volatility.
In contrast to Cardinal Health’s steady performance, the financial sector faced significant challenges on Friday, marked by rising oil prices and disappointing jobs data. Goldman Sachs emerged as a notable underperformer, seeing a drop of approximately 6% year-to-date and a striking 16% decline since reaching its peak earlier in January. The trust’s investment thesis for Goldman Sachs hinges on a surge in mergers, acquisitions, and initial public offerings, although this thesis is now under scrutiny due to ongoing market volatility.
Despite current setbacks, the trust remains optimistic about Goldman Sachs, especially with potential market entrants like SpaceX, Anthropic, and OpenAI eyeing public offerings. The bank’s dividend now holds a yield of about 2%, supported by a consistent share buyback program, which provides some cushion for investors during turbulent times.
Last December, the trust opted to downgrade Goldman to a hold-equivalent rating after realizing profits from shares priced in the $830s, and subsequently trimmed its holdings at around $950 earlier this year. However, following the recent pullback, a reassessment has led to an upgrade of Goldman Sachs back to a buy-equivalent rating.
As part of the CNBC Investing Club with Jim Cramer, subscribers are alerted to trading moves before they occur. Cramer implements a waiting period of 45 minutes post-trade alert issuance before executing any buy or sell orders and extends this period to 72 hours for stocks discussed on CNBC.
Investors are reminded that the information shared by the Investing Club is subject to terms and conditions and does not create any fiduciary responsibilities. Moreover, specific outcomes or profits are not guaranteed, emphasizing the inherent risks of investing.
